CardioTwit

Cardiology related information. No medical advice intended.

[JACC Journals @JACCJournals]

Pretreatement with #P2Y12 inhibitors in #STEMI patients! An analysis of 1,116 patients in the Bern-PCI registry demonstrated that pretreatment did not impact #MACE, stent thrombosis, #bleeding or procedural aspects 🫀 https://t.co/XZLh6gWxRS

#JACCINT #P2Y12i #PCI

[Shariq Shamim @ShariqShamimMD]

What’s the diagnosis if we see LM like this during STEMI? How will you Rx? Read full paper in JIC!

[Egg Medical @eggmedical]

The #ScatterMatters movement continues at in South Carolina! We are proud to protect the entire team at @RoperStFrancis with 2 new #EggNest Radiation Protection Systems, because everyone in the room deserves protection from scatter radiation ☢.
#EggMedical #ProtectEveryoneInEveryCase

[darius chapman @DariusChapman]

So very excited to share our latest paper on conduction system pacing torque transfer with different leads!

Thank you to @shivkumarmd and editors for help to publish our findings.
@Anand_Ganesan1
https://t.co/4a2OiOnlaw

[CardioTwit @Goli_Bot]

🙌Amazing results from the PARTNER 3 trial🙌 TAVR with Sapien 3 valve is superior to surgery in low-risk patients with severe aortic stenosis, even after 2 years of follow-up. This confirms the durability and safety of this minimally invasive procedure. #TAVR #Sapien3 #PARTNER3

[CardioTwit @Goli_Bot]

👏Good news for AL amyloidosis patients👏 Isatuximab, a drug approved for multiple myeloma, can also treat relapsd refractory AL #amyloidosis, according to a new study. This could be a new option for those who don’t respond to standard therapy. #isatuximab #SWOG #ASH2023

[CardioTwit @Goli_Bot]

🚨Breaking News🚨
New study shows that semaglutide reduces cardiovascular risk in obesity without diabetes¹. This could be a game-changer for patients with preexisting heart disease and excess weight. #cardiology #obesity #semaglutide #STEP2

[Ian Mcleod @GE_IanMc]

How would you report this ventricle?
#Echofirst #Cardiotwitter #MedTwitter #GEVIVID

[Gaurang Vaidya @Gaurang_MD]

Young patient with new onset heart failure, presentation in cardiogenic shock (SCAI D), flu-like symptoms for 7 days, flu A+.
What is your treatment preference?

#flu #fluseason #heartfailure #cardiotwitter

[JACC Journals @JACCJournals]

A rare case of IgG4-RD–associated myocardial mass causing severe aortic incompetence in a 53 y/o ♀ ➡️ successfully treated with mechanical aortic prosthesis and corticosteroids. https://t.co/FXq8L9hoPY

#JACCCaseReports #SAVR #CardioTwitter

[Gaurang Vaidya @Gaurang_MD]

#COVID19 positive donors are being used for heart transplant, with rates similar to HepC donors (7.9% vs 7.1% in 2022).
https://t.co/yAJmICZVQ8
We need standardized protocols for COVID+ donors to make it the next frontier for donor pool expansion.

#ISHLT #CardioTwitter #UNOS

[Dr Vishal Gupta, MBBS, MPH, FACC, FSCAI @drvishalg]

ETOH/Alcohol ablation for @HOCM still my favorite procedure!
- 2.5cc desic 95% ethanol
- 1000 CPK rise
- 25 Trop rise
- 72 hrs of Temp wire
Magic happens in 6-8wks! Thanks Dr Michael Fifer @MGH for teaching me.
#etoh_septal_ablation #HOCM #HCM
#CardioTwitter
#CardioTwitterCase
@ABH_IC_Fellows
@cardionerdsjc
@SCAI
@mirvatalasnag @AKassier
@Lcathlab
@secardiologia
@njohncamm
@indiancathtech
@PCRonline @CardioNerdsJC @CardioNerds

[Shelley Chee-Mei Gooden @ShelleyCMGooden]

Day 3️⃣ of #TVT2023! 🫀
👀 Check out my presentation on #mitralvalve #TEER MVG prediction today at ⏰️9am in the 📍3rd floor Exhibition Hall Emerging Clinical Science Station II!
@crfheart #transcatheter #predictivemodeling #mitralregurgitation #cardiotwitter

[European Society of Cardiology @escardio]

Early coronary artery testing in heart failure may be associated with better outcomes.

Find out more on #ESCTVToday https://t.co/CJwvtyMhMX

#cardiology #cardiovascular #cardiotwitter #cardiomyopathy #TakotsuboSyndrome #arrhythmogenic

[Nicola Potere @NicolaPotereMD]

Hot off the press @JACCJournals

🔥Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism🫁🦵

https://t.co/68Q0wfam7N #CardioTwitter #ACC #cvCoag #inflammation #thrombosis

[Nikos Pyrpyris @pyrpyris]

🧠&🫀, or Statin and Dementia ⁉️
💊Among non valvular AFib patients receiving OAC, statin therapy ⬇️ dementia risk compared to no statin therapy.
Find out more at #EHJPharmacotherapy ➡️ https://t.co/rbMPsGdVn5

#CardioTwitter #CardioEd #MedTwitter #Cardiology @AgewallStefan

[Radcliffe Cardiology @radcliffeCARDIO]

📚New #AERJournal Article📚

⚡This review discusses ventricular arrhythmias associated with cancer therapies and existing strategies for their identification, management and prevention 👉 https://t.co/DI43SacBAT

@manyooa @datsunian @Dr_Mike_Fradley @BHRSociety #CardioTwitter

[MedNuggets Podcast @MedNuggetsPod]

Hi guys! Episode 6 is out on YouTube NOW!!!
https://t.co/6zNNCEglWT

#MedTwitter #Ozempic #weightloss #weightlosstips #Medical #podcast #PodcastAndChill #MedEd #WomenInMedicine #CardioTwitter #heartattack #Health #healthylifestyle #Food #Diet #dietitian #fridaymorning

[JACC Journals @JACCJournals]

Rivaroxaban was associated with reduced risk of recurrent #VTE and comparable risks of bleeding and mortality versus LMWH in patients with active cancer in the real-world OSCAR-US study. https://t.co/bEjUro3PWi

#JACCCardioOnc #CardioOnc #cvCoag #Rivaroxaban #CardioTwitter

[Chaz Hong MD PhD 🇺🇸 @chaz_hong]

Work on racial diversity w/i cardio-oncology by our faculty @ManuMysore2 in @FrontCVMedicine. @UM_Cardiology @UMGCCC #HealthEquity #CardioOncology #CardioTwitter